A critical immunological and serological evaluation of patients with HTLV-III/LAV-related disorders.
Sirianni
M C
MC
Department of Allergy and Clinical Immunology, University of Rome, La Sapienza, Italy.
Luzi
G
G
Mezzaroma
I
I
Scano
G
G
Ragona
G
G
Soddu
S
S
Ensoli
B
B
Aiuti
F
F
D000386:AIDS-Related Complex / Q000276:immunology*; D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology*; D000328:Adult; D000914:Antibodies, Viral / Q000096:biosynthesis; D002648:Child; D003587:Cytomegalovirus / Q000276:immunology; D006678:HIV / Q000276:immunology; D004854:Herpesvirus 4, Human / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular; D007074:Immunoglobulin G / Q000096:biosynthesis; D007075:Immunoglobulin M / Q000096:biosynthesis; D007694:Killer Cells, Natural / Q000276:immunology; D008213:Lymphocyte Activation; D013601:T-Lymphocytes / Q000276:immunology*
D000914:Antibodies, Viral; D007074:Immunoglobulin G; D007075:Immunoglobulin M